A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.
Clinical trial NCT00042718 · COMPLETED
Trial details
- NCT number
- NCT00042718
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Enrollment
- 659
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.